Long-Term Risk of Colorectal Cancer in Patients With Prediabetes: A Comprehensive Systematic Review and Meta-Analysis

被引:0
|
作者
Keesari, Praneeth Reddy [1 ]
Jain, Akhil [2 ]
Pulakurthi, Yashwitha Sai [3 ]
Katamreddy, Rewanth R. [3 ]
Alvi, Ali Tariq [4 ]
Desai, Rupak [4 ]
机构
[1] Staten Isl Univ Hosp, Dept Internal Med, Staten Isl, NY USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd, Houston, TX 77030 USA
[3] New York Med Coll, St Michaels Med Ctr, Dept Internal Med, Newark, NJ USA
[4] Westside Hosp, Dept Internal Med, HCA Florida, Plantation, FL USA
关键词
prediabetes; hyperglycemia; colon cancer; colorectal cancer; meta-analysis; long-term; GLUCOSE; INSULIN; AGE;
D O I
10.15403/jgld-5527
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Prediabetes is often underdiagnosed and underreported due to its asymptomatic state in over 80% of individuals. Considering its role in promoting cancer incidence and limited evidence linking prediabetes and colorectal cancer (CRC), we conducted a systematic review and meta-analysis to evaluate the incidence of colorectal cancer in people with prediabetes. Methods: A comprehensive search through PubMed/Medline, Embase, Scopus, and Google Scholar was performed until June 1, 2022, to screen for studies reporting CRC incidence/risk in prediabetics. Binary random-effects models were used to perform meta-analysis and subgroup analyses. Sensitivity analysis was done using leave-one-out method. The quality of the studies was assessed by the Newcastle Ottawa Scale for observational studies. Results: Seven prospective and one retrospective study comprising 15 cohorts and a pooled number of 854,876 cases and 219,0511 controls were included in the analysis (2 Japan, 2 Korea, 1 Sweden, 1 UK, 1 China, and 1 USA). After combining all the studies, the forest plots for adjusted analysis shows a statistically significant increase in odds of having CRC with prediabetes (OR=1.16; 1.08-1.25, p< 0.01; I2=56.06%) and unadjusted analysis also shows a statistically significant increase in odds of having CRC with prediabetes (OR=1.62; 1.35-1.95, p< 0.01; I2=85.72% ). Sensitivity analysis using the Leave-one-out method did confirm equivalent results. Subgroup analysis based on type of study, the odds of developing CRC was higher in prospective studies (OR=1.175; 1.065-1.298) (p=0.001) than retrospective studies (OR=1.162; 1.033- 1.306) (p=0.012). The odds of developing CRC were not significantly higher in ages >60 (OR=1.446; 0.887-2.356) (p=0.139) compared to less than 60 years. The strongest association b/w prediabetes and CRC was found on a median 5-10 years (aOR=1.257; 1.029-1.534) (p=0.025) follow-up compared to < 5 years and 10 years and higher. Conclusions: This study showed that the odds of developing CRC is 16% higher in patients with prediabetes than those with normal blood glucose. Lifestyle modifications such as weight loss, proper diet, and exercise are essential to control prediabetes. This study further warrants a specific prediabetes screening for patients already at high risk of colorectal cancer with other risk factors.
引用
收藏
页码:386 / 393
页数:8
相关论文
共 50 条
  • [21] Long-Term Alcohol Consumption and Breast, Upper Aero-Digestive Tract and Colorectal Cancer Risk: A Systematic Review and Meta-Analysis
    Jayasekara, Harindra
    MacInnis, Robert J.
    Room, Robin
    English, Dallas R.
    ALCOHOL AND ALCOHOLISM, 2016, 51 (03): : 315 - 330
  • [22] Long-Term Unemployment and Suicide: A Systematic Review and Meta-Analysis
    Milner, Allison
    Page, Andrew
    LaMontagne, Anthony D.
    PLOS ONE, 2013, 8 (01):
  • [23] Long-Term Growth in Phenylketonuria: A Systematic Review and Meta-Analysis
    Ilgaz, Fatma
    Pinto, Alex
    Gokmen-Ozel, Hulya
    Rocha, Julio Cesar
    van Dam, Esther
    Ahring, Kirsten
    Belanger-Quintana, Amaya
    Dokoupil, Katharina
    Karabulut, Erdem
    MacDonald, Anita
    NUTRIENTS, 2019, 11 (09)
  • [24] Copper in colorectal cancer patients: a systematic review and meta-analysis
    Munoz-Bravo, Carlos
    Marin-Burdallo, Ines
    Gonzalez-Herrera, Lucas
    Torres, Carla Gonzalez-Palacios
    Lozano-Lorca, Macarena
    Jimenez-Moleon, Jose Juan
    Olmedo-Requena, Rocio
    CARCINOGENESIS, 2025, 46 (01)
  • [25] Prognostic value of tumor deposits for long-term oncologic outcomes in patients with stage III colorectal cancer: a systematic review and meta-analysis
    Jae Young Moon
    Min Ro Lee
    Gi Won Ha
    International Journal of Colorectal Disease, 2022, 37 : 141 - 151
  • [26] Prognostic value of tumor deposits for long-term oncologic outcomes in patients with stage III colorectal cancer: a systematic review and meta-analysis
    Moon, Jae Young
    Lee, Min Ro
    Ha, Gi Won
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (01) : 141 - 151
  • [27] Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
    Wekker, V
    van Dammen, L.
    Koning, A.
    Heida, K. Y.
    Painter, R. C.
    Limpens, J.
    Laven, J. S. E.
    van Lennep, J. E. Roeters
    Roseboom, T. J.
    Hoek, A.
    HUMAN REPRODUCTION UPDATE, 2020, 26 (06) : 942 - 960
  • [28] Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis
    Gorst, Catherine
    Kwok, Chun Shing
    Aslam, Saadia
    Buchan, Iain
    Kontopantelis, Evangelos
    Myint, Phyo K.
    Heatlie, Grant
    Loke, Yoon
    Rutter, Martin K.
    Mamas, Mamas A.
    DIABETES CARE, 2015, 38 (12) : 2354 - 2369
  • [29] Long-term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta-analysis
    Boyne, Devon J.
    Mickle, Alexis T.
    Brenner, Darren R.
    Friedenreich, Christine M.
    Cheung, Winson Y.
    Tang, Karen L.
    Wilson, Todd A.
    Lorenzetti, Diane L.
    James, Matthew T.
    Ronksley, Paul E.
    Rabi, Doreen M.
    CANCER MEDICINE, 2018, 7 (09): : 4801 - 4813
  • [30] L-TRUST: Long-term risk of cancer in patients under statins therapy. A systematic review and meta-analysis
    Craveiro, Nuno Sales
    Lopes, Bruno Silva
    Tomas, Lara
    Almeida, Sofia Fraga
    Palma, Helena
    Afreixo, Vera
    Matos, Luis Costa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (11) : 1431 - 1439